Important

This page can not be shown in IFRAME according to www.ascopost.com rules.
You will be redirected to https://www.ascopost.com/News/19597 in 3 seconds. Stop

. @US_FDA Grants Breakthrough Therapy Designation Pembrolizumab in NSCLC Lung Cancer - @ASCOPost #lcsm #CAImmun 6 years ago